Atnaujinkite slapukų nuostatas

El. knyga: Carbon Monoxide in Drug Discovery: Basics, Pharmacology, and Therapeutic Potential

Edited by (Georgia State University, Atlanta), Edited by
Kitos knygos pagal šią temą:
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

"Carbon monoxide, one of the smallest organic natural molecules, is widely known for its toxicity. Formation of CO via incomplete combustion is a major contributing factor to accidental or intentional CO poisoning, leading to severe health consequences or death. In addition, CO is a by-product of tobacco smoking, and has been associated with some of the harmful effects of smoking. However, less known and probably far more important is the recognition of the essential physiological roles of CO as a signaling molecule in mammals. Against over more than a century of negative connotation, the last few decades have proven that CO possesses a multitude of physiological roles and therapeutic functions including regulation of the immune response, cellular proliferation, and control of cell survival. This concept is supported by the discovery that CO is produced by all cells and more so under conditions of stress. This book comprehensively summarizes key aspects of CO's endogenous roles, therapeutic functions, and challenges that we face in its development as a therapeutic agent. We hope this preface will provide a thread for reading this book and a birds-eye view of the landscape for understanding this field, and more importantly lay out the challenges ahead in understanding the detailed mechanisms of action of CO and in its development as a therapeutic agent. We have divided the book into four sections that provide a framework for the reader to follow the evolution of CO from an accepted poison to a bioactive molecule that may offer enormous clinical benefits"--

CARBON MONOXIDE IN DRUG DISCOVERY

An insightful reference for the latest physiological and therapeutic studies of carbon monoxide

In Carbon Monoxide in Drug Discovery: Basics, Pharmacology, and Therapeutic Potential, a team of distinguished authors delivers foundational knowledge, the latest research, and remaining challenges regarding the physiological roles and therapeutic efficacy of carbon monoxide (CO). The editors have included a broad selection of resources from leading experts in the field that discuss the background and physiological roles of CO, a variety of delivery forms including CO prodrugs using benign carriers, CO sensing, therapeutic applications, and clinical trials.

Organized by topic to allow each chapter to be read individually, the book covers a wide range of topics, from physiological and patho-physiological mechanisms at the molecular level to clinical applications for multiple disease processes.

The editors of Carbon Monoxide in Drug Discovery have created a compelling argument for shifting the accepted understanding of CO from poison to bioactive molecule with enormous clinical benefits. Readers will also benefit from:

  • A thorough introduction to the background and physiological actions of carbon monoxide, including endogenous CO production in sickness and in health
  • Comprehensive explorations of CO delivery forms, including non-carrier formulations, metal-carbonyl complexes, and organic CO donors
  • Practical discussions of carbon monoxide sensing and scavenging, including fluorescent probes for intracellular carbon monoxide detection
  • In-depth examinations of the therapeutic applications of CO, including CO in solid organ transplantation

Perfect for professors, graduate students, and postdocs in the fields of biology, pharmacology, immunology, medicinal chemistry, toxicology, and drug delivery, Carbon Monoxide in Drug Discovery: Basics, Pharmacology, and Therapeutic Potential is also an invaluable resource for industrial scientists in these areas.

List of Contributors
viii
Preface: Carbon Monoxide: Promises and Challenges in Its Pharmaceutical Development xii
Section I General Background and Physiological Actions
1(194)
1 Endogenous CO Production in Sickness and in Health
3(24)
Ladle Kimberly De La Cruz
Binghe Wang
2 Molecular Mechanisms of Actions for CO: An Overview
27(17)
Rodrlgo W. Alves de Souza
Leo E. Otterbein
Nils Schatlner
3 Pharmacokinetic Characteristics of Carbon Monoxide
44(44)
Xiaoxiao Yang
Mingjia Wang
Chalet Tan
Wen Lu
Binghe Wang
4 Carbon Monoxide and Energy Metabolism
88(9)
Daniela Dias-Pedroso
Nuno Soares
Helena L.A. Vieira
5 Role of CO in Circadian Clock
97(11)
Hiroaki Kitagishi
Ikuko Sagami
6 Carbon Monoxide and Mitochondria
108(10)
Claude A. Piantadosi
7 Carbon Monoxide, Oxygen, and Pseudohypoxia
118(18)
Grace E. Otterbein
Michael S. Tift
Ghee Rye Lee
8 Nitric Oxide in Human Physiology: Production, Regulation, and Interaction with Carbon Monoxide Signaling
136(24)
Maryam K. Mohammed
Brian S. Zuckerbraun
9 When Carbon Monoxide Meets Hydrogen Sulfide
160(15)
Rui Wang
10 Biliverdin and Bilirubin as Parallel Products of CO Formation: Not Just Bystanders
175(20)
Libor Vitek
Section II Delivery Forms
195(124)
11 Delivery Systems and Noncarrier Formulations
197(6)
James Byrne
Christoph Steiger
Jakob Wollborn
Giovanni Traverso
12 Metal-Based Carbon Monoxide-Releasing Molecules (CO-RMs) as Pharmacologically Active Therapeutics
203(20)
Roberta Foresti
Djamal Eddine Benrahta
Shruti Mohan
Roberto Motterlini
13 Organic CO Donors that Rely on Photolysis for CO Release
223(9)
Yi Liao
14 Organic Carbon Monoxide Prodrugs that Release CO Under Physiological Conditions
232(27)
Zhengnan Yuan
Binghe Wang
15 Targeted Delivery of Carbon Monoxide
259(27)
Lisa M. Berreau
16 Anesthesia-Related Carbon Monoxide Exposure
286(16)
Richard J. Levy
17 Natural Products that Generate Carbon Monoxide: Chemistry and Nutritional Implications
302(17)
Ladie Kimberly De La Cruz
Binghe Wang
Section III Carbon Monoxide Sensing and Scavenging
319(26)
18 Fluorescent Probes for Intracellular Carbon Monoxide Detection
321(24)
Ryan R. Walvoord
Morgan R. Schneider
Brian W. Michel
Section IV Therapeutic Applications
345(183)
19 CO in Solid Organ Transplantation
347(13)
Roberta Foresti
Roberto Motterlini
Stephen Immenschuh
20 Carbon Monoxide in Lung Injury and Disease
360(17)
Stefan W. Ryter
21 Carbon Monoxide in Acute Brain Injury and Brain Protection
377(8)
Alexandra Mazur
Madison Fangman
Rani Ashouri
Hannah Pamplin
Shruti Patel
Sylvain Dore
22 CO as a Protective Mediator of Liver Injury: The Role of PERK in HO-1 / CO-Mediated Maintenance of Cellular Homeostasis in the Liver
385(16)
Yeonsoo Joejeongmin Park
Mihyang Do
Stefan W. Ryter
Young-Soon Surh
Uh-Hyun Kim
Hun Taeg Chung
23 CO and Cancer
401(22)
James N. Arnold
Joanne E. Anstee
24 CO and Diabetes
423(11)
Rebecca P. Chow
Hongjun Wang
25 Carbon Monoxide and Acute Kidney Injury
434(19)
Mark de Caestecker
26 CO as an Antiplatelet Agent: An Energy Metabolism Perspective
453(13)
Patrycja Kaczara
Kamil Przyborowskl
Roberto Motterlini
Stefan Chlopicki
27 CO in Gastrointestinal Physiology and Protection
466(16)
Katarzyna Magierowska
Marcin Magierowski
28 Carbon Monoxide and Sickle Cell Disease
482(15)
Edward Gomperts
John Belcher
Howard Levy
Greg Vercellotti
29 CO and Pain Management
497(14)
Olga Pol
30 Clinical Trials of Low-Dose Carbon Monoxide
511(17)
Edward Gomperts
Andrew Gomperts
Howard Levy
Index 528
Binghe Wang, PhD, is Regents Professor of Chemistry, Georgia Research Alliance Eminent Scholar, and Director for the Center for Diagnostics and Therapeutics at Georgia State University.

Leo E. Otterbein, PhD, is Professor of Surgery at Harvard Medical School.